Cancer biology and molecular genetics of A3 adenosine receptor

被引:0
|
作者
Chiara Mazziotta
John Charles Rotondo
Carmen Lanzillotti
Giulia Campione
Fernanda Martini
Mauro Tognon
机构
[1] University of Ferrara,Laboratories of Cell Biology and Molecular Genetics, Section of Experimental Medicine, Department of Medical Sciences, School of Medicine
[2] University of Ferrara,Center for Studies on Gender Medicine—Department of Medical Sciences
[3] University of Ferrara,Laboratory for Technologies of Advanced Therapies (LTTA)
来源
Oncogene | 2022年 / 41卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
A3 adenosine receptor (A3AR) is a cell membrane protein, which has been found to be overexpressed in a large number of cancer types. This receptor plays an important role in cancer by interacting with adenosine. Specifically, A3AR has a dual nature in different pathophysiological conditions, as it is expressed according to tissue type and stimulated by an adenosine dose-dependent manner. A3AR activation leads to tumor growth, cell proliferation and survival in some cases, while triggering cytostatic and apoptotic pathways in others. This review aims to describe the most relevant aspects of A3AR activation and its ligands whereas it summarizes A3AR activities in cancer. Progress in the field of A3AR modulators, with a potential therapeutic role in cancer treatment are reported, as well.
引用
收藏
页码:301 / 308
页数:7
相关论文
共 50 条
  • [41] Nucleoside prodrugs of A3 adenosine receptor agonists and antagonists
    Besada, Pedro
    Mamedova, Liaman K.
    Palaniappan, Krishnan K.
    Gao, Zhan-Guo
    Joshi, Bhalchandra V.
    Jeong, Lak Shin
    Civan, Mortimer M.
    Jacobson, Kenneth A.
    [J]. COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, 2006, 71 (06) : 912 - 928
  • [42] Evaluation Of Novel A3 Adenosine Receptor Agonist In Hypertension
    Zapata-Sudo, Gisele
    Rocha, Bruna
    Da Silva, Jaqueline S.
    Montagnoli, Tadeu
    Pedreira, Julia G.
    Barreiro, Eliezer J.
    [J]. CIRCULATION RESEARCH, 2023, 133
  • [43] Recent improvements in the field of A3 adenosine receptor ligands
    Baraldi, PG
    Fruttarolo, F
    Tabrizi, MA
    Romagnoli, R
    Preti, D
    Carriòn, MD
    Iaconinoto, A
    Borea, PA
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (11) : 1507 - 1519
  • [44] Cloning and characterisation of the human adenosine A3 receptor gene
    Murrison, EM
    Goodson, SJ
    Edbrooke, MR
    Harris, CA
    [J]. FEBS LETTERS, 1996, 384 (03) : 243 - 246
  • [45] Analysis of A3 adenosine receptor overexpression for cardiac protection
    Auchampach, JA
    [J]. DRUG DEVELOPMENT RESEARCH, 2002, 56 (04) : 552 - 552
  • [46] Pharmacology of the Adenosine A3 Receptor in the Vasculature and Essential Hypertension
    Ho, Ming-Fen
    Low, Leanne M.
    Rose'Meyer, Roselyn B.
    [J]. PLOS ONE, 2016, 11 (02):
  • [47] A1 and A3 adenosine receptor agonists:: an overview
    Baraldi, PG
    Cacciari, B
    Romagnoli, R
    Spalluto, G
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 1999, 9 (05) : 515 - 527
  • [48] Pharmacological characterisation of novel adenosine A3 receptor antagonists
    Barkan, Kerry
    Lagarias, Panagiotis
    Stampelou, Margarita
    Stamatis, Dimitrios
    Hoare, Sam
    Safitri, Dewi
    Klotz, Karl-Norbert
    Vrontaki, Eleni
    Kolocouris, Antonios
    Ladds, Graham
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [49] Anticancer activity study of A3 adenosine receptor agonists
    Marucci, Gabriella
    Santinelli, Claudia
    Buccioni, Michela
    Navia, Aleix Marti
    Lambertucci, Catia
    Zhurina, Anastasia
    Yli-Harja, Olli
    Volpini, Rosaria
    Kandhavelu, Meenakshisundaram
    [J]. LIFE SCIENCES, 2018, 205 : 155 - 163
  • [50] New strategies for the synthesis of A3 adenosine receptor antagonists
    Baraldi, PG
    Bovero, A
    Fruttarolo, F
    Romagnoli, R
    Tabrizi, MA
    Preti, D
    Varani, K
    Borea, PA
    Moorman, AR
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (19) : 4161 - 4169